The difference between the subgroups was approximately significant ( Q =6.05; P =.05).
Excerpts
However, the AA contents in the flour were approximately ten times lower than those observed in the respective pulps, which allows us to state that drying at 55 °C caused a highly significant reduction in the AA content of the raw and cooked pulps ( p ≤ 0.05).
In community hospitals, the drug proportion showed an increasing trend before the intervention ( p > 0.05), while at the time of the intervention, a sudden decline occurred ( p < 0.001).
borderline significancep = 0.050
PFS did not differ between ribociclib and palbociclib ( p = 0.192); OS favored ribociclib at borderline significance ( p = 0.050), but this was not confirmed in Cox regression.
In community hospitals, the CCE showed a decreasing trend before intervention ( p < 0.05), and at the moment of intervention. there was a significant increase ( p < 0.001).
Results were considered significant at P ≤ 0.05 and marginally significant between P > 0.05 and P ≤ 0.10.
In the tSCS group, gait function measured by the WISCI-II showed a borderline significant improvement (Friedman test: p = 0.05); however, post hoc analysis revealed no significant differences at post-intervention (Wilcoxon test: p = 0.109) or at follow-up ( p = 0.109) ( Figure 5 ).
As a result, between 16 and 66 pathways between the three contrasts were rendered nominally significant ( p < 0.05).
The HSI and VSI presented an increasing trend from BFLM17 to BFLM68 group ( p < 0.05).
Nepal: The baseline trend did not indicate a statistically significant rate of change, but showed an increasing trend after the first intervention (0.004; p < 0.05).
Based on p-value criteria, the correlation coefficient’s statistical significance is evaluated as follows: not significant at p > 0.10, moderately significant at p < 0.05, and highly significant at p < 0.01.
A marginally significant association was found in retrospective cohorts (OR = 1.78, 95% CI: 1.00–3.17, P = 0.05, I 2 = 91%), whereas no significant associations were identified in women aged >32 years (OR = 2.08, 95% CI: 0.89–4.83, P = 0.09, I 2 = 99%) or small-sample studies (<1,000 participants, OR = 1.68, 95% CI: 0.54–5.22, P = 0.37, I 2 = 69%).
showed a trendP = 0.05
In direct comparisons between the active treatment groups, combined therapy showed a trend toward lower mortality compared with aspirin monotherapy at 28 days (HR 0.52, 95% CI: 0.27-1.00, P = 0.05), with significant benefit at 90 days (HR: 0.47, 95% CI: 0.27-0.83, P < 0.01) and 1 year (HR: 0.59, 95% CI: 0.39-0.91, P = 0.02).
There was an interaction approaching significance, F (1, 25) = 4.14, p = 0.05, η p 2 = 0.14.
While a borderline significant association between low level laser and treatment effects was identified in studies involving myogenous TMD ( P = .05), this pattern was not consistently observed across other interventions ( Table S10 , Supplemental Digital Content 13). 3.5.
In addition, a marginally significant group by time effect was found for positive adaptation coping, F (1, 46.18) = 3.94, p = 0.05, 95% CI: −0.03–4.65, Hedges’ g = 1.08, with the intervention group reporting improvements in positive adaptation coping from pre- ( M = 24.80, SD = 3.95) to post- ( M = 25.50, SD = 3.18) assessment compared to participants in the waitlist control group (preassessment: M = 23.57, SD = 4.89; post-assessment: M = 21.95, SD = 3.41).
near statistical significancep = 0.050
Although no strongly significant differences were detected, borderline values were observed for Xmed in Conditions 1 and 5 ( p = 0.090) and reached near statistical significance in Condition 2 ( p = 0.050).
A highly significant interaction was found between FM level and taurine level on FBW, WGR, and SGR ( P < 0.05).
For both CIN2+ or CIN3+, the AUC values for HR-HPV and LBC co-testing, HR-HPV testing, and LBC showed a decreasing trend in both premenopausal and postmenopausal (all P <0.05) (Fig. 2 ).
63 inferential comparisons were evaluated; 38 were nominally significant at p < 0.05, and 35 remained significant after Benjamini–Hochberg FDR correction (q < 0.05).
In contrast, within the novice group, activation was significantly higher in the rotated-orientation condition than in the normal-orientation condition at Ch7 [ F (1,46) = 5.198, p = 0.027, η 2 = 0.102], whereas the difference at Ch6 reached only marginal significance [ F (1,46) = 3.846, p = 0.05, η 2 = 0.077] (see Figure 4 ). 3.3.
A borderline significant ( P = .050) decrease in QAct scores was evidenced from baseline to the 3-month visit and remained stable ( P = .100) at 12 months.
Unilateral clubfoot had a slightly higher CIA, although the difference was only marginally significant ( p = 0.05; effect size r = 0.40).
Among 188 KPC-producing CRKP strains, multivariate analysis identified that traT (aHR = 3.12; p = 0.05, borderline significant) and capsular types (p = 0.02) were independently associated with 30-day all-cause mortality, irrespective of ceftazidime-avibactam usage (aHR = 0.38; p = 0.002), pneumonia (aHR = 1.84; p = 0.01), Pitt score (aHR = 1.27; p < 0.001) and traJ presence (aHR = 1.96; p = 0.48) (Table 5 ).
We found that while all mice in the control group (4/4) developed detectable tumors by day 17 that progressed rapidly thereafter, tumors in the IGF-Trap-treated group were only detectable in 1/5 mice at that time, and the growth rate in the majority of treated mice was lower than in the control group, although the difference under these experimental conditions did not reach statistical significance (defined as P ≤ 0.05) ( Figure 3B ).